Christine Fox
2022
In 2022, Christine Fox earned a total compensation of $810.9K as Chief Financial Officer at Mereo BioPharma Group plc.
Compensation breakdown
| Bonus | $166,416 |
|---|---|
| Option Awards | $271,627 |
| Salary | $332,833 |
| Other | $40,063 |
| Total | $810,939 |
Fox received $332.8K in salary, accounting for 41% of the total pay in 2022.
Fox also received $166.4K in bonus, $271.6K in option awards and $40.1K in other compensation.
Rankings
In 2022, Christine Fox's compensation ranked 3,474th out of 5,756 executives tracked by ExecPay. In other words, Fox earned more than 39.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,474 out of 5,756 | 40th |
Division Manufacturing | 1,968 out of 3,133 | 37th |
Major group Chemicals And Allied Products | 940 out of 1,419 | 34th |
Industry group Drugs | 879 out of 1,320 | 33rd |
Industry Pharmaceutical Preparations | 642 out of 966 | 34th |
Source: SEC filing on April 24, 2024.
Fox's colleagues
We found two more compensation records of executives who worked with Christine Fox at Mereo BioPharma Group plc in 2022.